The corona virus continues to thrive in Latin America and the Caribbean, with more than 24 million cases and more than 757,000 deaths.
Latin America continues to strengthen health measures to stem the tide of Covit-19, which is affecting Brazil, and new hopes sprouted this Friday with the announcement of two national vaccination programs.
The corona virus, which has amassed more than 24 million cases and more than 757,000 deaths in Latin America and the Caribbean, continues to thrive in the region, raising concerns about the increasing incidence of Brazilian variant, which is considered more contagious than the original strain.
At the South American Institute, more than 300,000 deaths have already been recorded, and the epidemic appears to be widespread. To try to prevent it, the governor of S பாo Paulo, Joao Toria, announced that the prestigious Button company (already producing under the Chinese Koronavok agreement) was developing the first local vaccine, and that it could begin using it in May with the expectation that the first local vaccine, called Bhutanwak, would produce 40 million doses.
But it must first get approval from the health regulator to begin its clinical trials in April.
A plan released in a fortnight that the government of Jair Bolsanaro supported the investment is also waiting for the green light for the tests, as announced by the Ministry of Science. This is the Versamune-Covey-2 FC developed by the Ribeirao Brito Medical Faculty located in Sவோo Paulo.
On Thursday, infections in the country rose to more than 100,000 for the first time in 24 hours, leading to even more deaths in the third mourning country after the United States.
Faced with this situation, former President Luiz Inacio Lula da Silva condemned the “greatest genocide” in the country’s history and harshly criticized Bolsanaro.
“If I have a little pride, I have to apologize to the families of the 300,000 people who died from the corona virus, and to the millions of victims,” Lula told a German weekly.
When asked about these reports, WHO Emergency Director Michael Ryan said: “Regardless of ideological perspective, most leaders try to do the best for their people. They don’t always do it right. “
Despite optimism about vaccines, the reality of the epidemic led to new restrictions in many countries in the region, as well as in Europe.
Chile, which is spearheading the anti-coagulation vaccination process in Latin America, will control more than 80% of its 17 million population as of Saturday.
“It is important for people to understand that we are experiencing a worrying situation,” Chilean Health Minister Enrique Paris told a news conference on Thursday that a high number of infections had been reported daily since the start of this Friday, registering 7,626 new cases.
The integrated health network occupies 95% of the intensive care units.
In Argentina, the latest daily infections this Friday rose to nearly 13,000, the highest score since January. Thus, it amassed 2.29 million infections and 55,235 deaths since the beginning of the crisis.
On Thursday the government announced it would suspend regular flights with Chile, Brazil and Mexico from Saturday, while borders are closed to tourists.
Infections are also on the rise in countries such as Uruguay, Venezuela, Peru and Paraguay, which is attributed to the outbreak of the Brazilian variant (B1) to the current wave of epidemics.
Guatemala, meanwhile, decided this Friday to limit access to tourist destinations, anticipate holiday moves during Holy Week, and due to the concentration of hospitals.
The Ministry of Health has established that “access to beaches, lakes, rivers, resorts and water parks across the country” will be limited to “more than 100 people”.
Controversy in Europe
The production, distribution and access of vaccines continue to cause tension around the world.
About 180 UN. Countries pledged to promote equal access to vaccines.
In the speech, they expressed concern about inequalities in distribution “between countries and countries”.
In that regard, the WHO has asked the international community to donate 10 million doses “immediately” to 20 countries through the Kovacs mechanism. Director General of the company Tetros Adanom Caprais said.
“Many countries can give doses by slightly changing their vaccination programs,” he said.
In Europe, Brussels and the United Kingdom have been embroiled in controversy over access to astrogenic vaccines.
The European Pharmaceuticals Association (EMA) on Friday approved a plant to manufacture the vaccine in the Netherlands, after the European Union (EU) said it was ready to block exports of AstraZeneca levels outside the region, citing supply problems.
The EMA estimates that this will bring the number of factories producing the active ingredient in the drug Astrogeneca to four.
The EU exported about 21 million doses of all vaccines produced in its territory to the UK, but did not receive any of the drugs manufactured in the English Channel, although the contract with AstraZeneca was awarded for distribution from two British factories. (I)